Best Hormone therapy for prostate cancer Clinics in the World: 47 Top-Rated Centers

Prof. Dr. Mustafa Özdoğan has managed 900+ prostate cancer cases over 26 years of experience as Head of Medical Oncology. Hormone therapy may cost around $3,000 – typically covering PSMA PET scan, blood tests, doctor consultation, and transfers. The JCI-accredited hospital includes advanced diagnostics like Gallium-68 imaging. Prof. Özdoğan published 40+ articles and holds European Medical Oncology Association membership.

Memorial Şişli Hospital's hormone therapy program for prostate cancer is supported by experienced oncologists like Dr. Serkan Keskin, who has over 25 years of experience in medical oncology with expertise in targeted therapies and immunotherapy. The JCI-accredited facility offers comprehensive cancer care with advanced treatment protocols.

Centro Médico Teknon offers hormone therapy for prostate cancer under the guidance of Prof. Jaume Capdevila, a leading oncologist with expertise in digestive and pancreatic cancers, recognized by EORTC, ESMO, and ASCO for his contributions to oncology.

Medipol University Hospital is one of the largest multi-specialty medical institution in Turkey. Daily, over 1,200 patients trust their health to Medipol's experts. The hospital is equipped with advanced technologies, i.e, Da Vinci Surgical System, Cyber and Gamma Knives. Doctors specialize in cancer, neurological, and cardiovascular treatment. Organ transplantation, bone marrow transplant and IVF are among key specialties of the hospital.

Memorial Hospital Bahçelievler (Memorial Bahçelievler Hastanesi) is a multidisciplinary medical center in Istanbul with an eco-friendly design. There are a lot of green areas on the hospital territory, which contribute to patients’ psychological comfort and their speedy recovery.

The medical facility specializes in oncology treatments, cardiovascular surgery, orthopedics, brain surgery, urology, gynecology, general and robotic surgery.

Anadolu Medical Center offers hormone therapy for prostate cancer with Johns Hopkins affiliation and American treatment standards at 20-30% lower costs than European clinics. The multi-disciplinary team includes professors of uro-oncology, radiation oncology, and medical oncology. Treatment may cost around $2,610, typically covering diagnostics and consultations. Advanced diagnostics include PSMA PET CT scans detecting 5mm tumors. The center provides all-inclusive translation services and free airport transfers for international patients.

Hormone therapy for prostate cancer is provided at JCI-accredited Hisar Hospital Intercontinental, which receives over 500,000 patients annually. The oncology department includes specialists like Dr. Mustafa Solak, a medical oncologist trained at Hacettepe University Cancer Institute and MD Anderson Cancer Center, specializing in prostate cancer treatment.

Dr. David Sarid, Chief of Oncology at Sourasky Medical Center, pioneered immunotherapy and targeted therapy in Israel with 30+ cancer treatment publications. The initial consultation for hormone therapy may cost around $900, typically including a comprehensive treatment plan development and medical document review. Sourasky is JCI-accredited and ranked among the Top 10 most popular hospitals worldwide for medical tourism by Newsweek.

Prof. Andreas Gross, Chief Physician of Urology at Asklepios Barmbek, is a TOP German urologist specializing in prostate cancer treatment. Recognized by leadingmedicineguide, he offers organ-preserving therapies including HIFU and TUR. The clinic handles 80,000 patients annually and is part of Germany's largest hospital network.

Memorial Ataşehir Hospital is a JCI-accredited facility specializing in oncology, with a focus on hormone therapy for prostate cancer. Prof. Dr. Kamil Yalçın Polat brings 35 years of experience of surgical oncology experience, having trained at Memorial Sloan Kettering Cancer Center and Mount Sinai Hospital. His expertise in hepatobiliary cancers and international research contributions enhance the hospital's multidisciplinary approach to prostate cancer management.